22 May 2017| Geneva −− Two innovative pig health products are now available to tackle a major foodborne hazard, which causes approximately 30% of epilepsy in humans in the developing world.

A novel vaccine developed by Indian Immunological Limited (IIL) and GALVmed, based on technology from Professor Marshall Lightowlers at the University of Melbourne for the prevention of porcine cysticercosis has been recently licensed in India. This vaccine known as Cysvax® was commercially developed by IIL and since November 2016 is available for sale in India.

• Read more

15 May 2017 | Geneva −− Several mathematical models have been published which attempt to simulate transmission of Taenia solium and the impact of various intervention measures. This paper takes a different approach. A logical model is presented of the risk for T. solium to be transmitted by pigs which are subjected to anti-T. solium vaccination and chemotherapy, or chemotherapy alone.

• Read the article

02 June 2016 | Geneva -- T. solium-induced neurocysticercosis is a global public health problem with important socioeconomic impacts. Neurocysticercosis, the cause of serious, potentially lethal health conditions such as epilepsy, remains an under-recognized public health concern.

• Read the reports

December 2016 | Geneva −− Living in close proximity to animals and in poor hygienic circumstances can lead to the spread of diseases. The pig tapeworm Taenia solium, which can cause preventable epilepsy in humans, is an example. It is prevalent in Madagascar where WHO is supporting the Ministry of Health in controlling this parasite through a 'One-Health approach'. This approach recognizes that the health of people is connected to that of animals and that an intersectoral, collaborative approach is needed to tackle the spread of diseases.

• Read more